On Apr. 24, 2025, Thermo Fisher Scientific announced it will will invest an additional $2 billion in the United States over the next four years, strengthening American innovation, manufacturing and economic competitiveness across the life sciences sector.

The $2 billion investment over the next four years includes: $1.5 billion in capital expenditures to enhance and expand U.S. manufacturing operations, and complemented by $500 million in R&D focused on high-impact innovation.

This investment builds on Thermo Fisher’s industry-leading foundation in U.S. manufacturing and innovation. The company has 64 U.S. manufacturing operations, located in 37 states, making analytical instruments, specialty diagnostics and life sciences solutions, as well as providing contract development and manufacturing services for pharmaceutical innovators.